Atlas Trials

Conbercept in Choroidal Neovascularization Secondary to Uveitis

Clinical trial NCT02934841 · UNKNOWN

Trial details

NCT number
NCT02934841
Sponsor
Chongqing Medical University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Choroidal NeovascularizationUveitis
Start date
2016-11-01
Primary completion
2018-03-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.